Hepatitis B virus preS1 functions as a transcriptional activation domain

Journal of General Virology

Volumn 78, Issue 5, 1997, Pages 1083-1086

  Kim, Hee Sun ^a   Ryu, Chun Jeih ^a   Hong, Hyo Jeong ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; TRANSCRIPTION FACTOR; VIRUS FUSION PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; CHO CELL; CONTROLLED STUDY; DELETION MUTANT; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION INITIATION; YEAST;

EID: 0030968921     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-5-1083     Document Type: Article

References (26)

1. Balsano, C., Avantaggiati, M. L., Natoli, G., De Marzio, E., Will, H., Perricaudet, M. & Levrero, M. (1991). Full-length and truncated versions of the hepatitis B virus X protein transactivate the c-myc protooncogene at the transcriptional level. Biochemical and Biophysical Research Communications 176, 985-992.
2. Beasley, R. (1988). Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer Research 61, 1942-1956.
3. Dejean, A., Bougueleret, L., Grzeschik, K. H. & Tiollais, P. (1986). Hepatitis B virus DNA integration in a sequence homologous to v-erb A and steroid receptor genes in a hepatocellular carcinoma. Nature 322, 70-72.
4. de The, H., Marchio, A., Tiollais, P. & Dejean, A. (1987). A novel steroid thyroid hormone receptor-related gene is appropriately expressed in human hepatocellular carcinoma. Nature 330, 667-670.
5. Fields, S. & Jang, S. K. (1991). Presence of a potent transcription activating sequence in the p53 protein. Science 249, 1046-1049.
6. Ganem, D. & Varmus, H. E. (1987). The molecular biology of hepatitis B viruses. Annual Review of Biochemistry 56, 651-693.
7. Gietz, D., St Jean, A., Woods, R. A. & Schiestl, R. H. (1992). Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Research 20, 1425.
8. Gorman, C. M., Moffat, L. F. & Howard, B. H. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Molecular and Cellular Biology 2, 1044-1051.
9. Kekule, A. S., Lauer, U., Meyer, M., Caselman, W. H., Hofschneider, P. H. & Koshy, R. (1990). The preS/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 343, 457-461.
10. Kim, Y. S. & Kang, H. S. (1984). Cloning and expression of hepatitis B virus surface antigen gene. Korean Biochemical Journal 17, 70-79.
11. t transactivator utilizes AP-1 and other transcription factors for transactivation. Hepatology 19, 23-31.
12. Lee, C. Q., Yun, Y., Hoeffler, J. P. & Habener, J. F. (1990). Cyclic-AMP-responsive transcription activation of CREB-327 involves interdependent phosphorylated subdomains. EMBO Journal 9, 4455-4465.
13. t: activation of NF-κB, selective inhibition by antioxidants and integral transmembrane localization. EMBO Journal 11, 2991-3001.
14. Miller, J. H. (1972). Experiments in Molecular Genetics. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
15. Moriarty, A. M., Hoyer, B. H., Shih, J. W., Gerin, J. L. & Hamer, D. H. (1981). Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector. Proceedings of the National Academy of Sciences, USA 78, 2606-2610.
16. Nakamura, T., Tokino, T., Nagaya, T. & Matsubara, K. (1988). Microdeletion associated with integration process of hepatitis B virus DNA. Nucleic Acids Research 16, 4865-4873.
17. Neurath, A. R., Kent, S. B. H., Strick, N. & Parker, K. (1986). Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46, 429-436.
18. Neurath, A. R., Seto, B. & Strick, N. (1989). Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 7, 234-236.
19. Okuda, K. (1992). Hepatocellular carcinoma: recent progress. Hepatology 15, 948-963.
20. Park, S. S., Jin, B. R., Han, M. H. & Hong, H. J. (1994). Expression of soluble and functional single-chain antibody in Escherichia coli. Molecules and Cells 4, 413-417.
21. Ptashne, M. (1988). How eukaryotic transcriptional activators work. Nature 335, 683-688.
22. Ramesh, R., Panda, S. K., Jameel, S. & Rajasambandam, P. (1994). Mapping of the hepatitis B virus genome in hepatocellular carcinoma using PCR and demonstration of a potential trans-activator encoded by the frequently detected fragment. Journal of General Virology 75, 327-334.
23. Sadowski, I., Ma, J., Triezenberg, S. & Ptashne, M. (1988). GAL4-VP16 is an unusually potent transcriptional activator. Nature 335, 563-564.
24. Sherker, A. & Marion, P. (1991). Hepadnaviruses and hepatocellular carcinoma. Annual Review of Microbiology 45, 475-508.
25. Wang, J., Cheniverse, X., Henglein, B. & Brechot, C. (1990). Hepatitis B virus integration in a cyclin gene in a hepatocellular carcinoma. Nature 343, 555-557.
26. Williamson, M. P. (1994). The structure and function of proline-rich regions in proteins. Biochemical Journal 297, 249-260.